August JAAD: Rapid Clinical Response to Nemolizumab in Dermatologic Diseases Associated with Pruritus and Burning: A Multicenter Case Series

February 16, 2026

Refractory pruritus and burning symptoms can persist despite extensive evaluation and multiple therapies. In this episode, Jenny Eileen Murase, MD, FAAD and Elisa Gallo, MD, FAAD discuss how careful diagnostic workup and targeted treatment may offer rapid symptom relief while preserving clinical vigilance.

Summary

Availability:

On-Demand

Expires on Feb 16, 2029

Credit Offered:

0.5 CME Credit

Recommended

Markers of Risk Not Pre-Melanomas: Case-Based Management of Dysplastic Nevi

February 9, 2026

Dysplastic nevi often generate uncertainty about melanoma risk and the need for re-excision. Listen as Suephy C. Chen, MD, FAAD and Lilia Correa-Selm, MD, FAAD reflect on how evidence-based classification and patient-centered follow-up can inform practical, risk-aware decision-making.

0.5 CME

Staging, Work-Up, and Management of High Risk Cutaneous Squamous Cell Carcinoma

February 2, 2026

High-risk cutaneous squamous cell carcinoma challenges clinicians to distinguish common disease from lesions with potentially serious outcomes. Join Kathryn Shahwan, MD, FAAD and M. Laurin Council, MD, FAAD as they discuss how thoughtful staging, risk stratification, and multidisciplinary care can guide management and long-term surveillance.

0.5 CME

Atopic Dermatitis in Pediatric Patients

February 23, 2026

Advances in systemic therapy are changing how pediatric atopic dermatitis is understood and treated. Listen as Amy S. Paller, MD, FAAD and Emily Newsom, MD, FAAD explore how emerging treatments may influence disease course, comorbidities, and quality of life for children and their families.

0.5 CME

Question of the Week Self-Assessment - 2026

13.25 CME

The Evolving Toolbox for Treating Difficult Warts

November 3, 2025

Despite their common condition, warts are often stubborn to the most routine care. On this episode, Peter Friedman, MD, FAAD and Hillary Johnson-Jahangir, MD, PhD, FAAD highlight how today’s therapeutic toolbox is giving dermatologists fresh options for treatment.

0.5 CME

Hidradenitis Suppurativa

March 30, 2026

A growing range of therapeutic options is influencing care for patients with hidradenitis suppurativa. Listen as Jennifer Hsiao, MD, FAAD and Jacquelyn Dosal, MD, FAAD examine how individualized, multimodal approaches can support more effective disease control.

0.5 CME

Best Practices for Hair Care and Styling in Patients with Alopecia

January 26, 2026

Managing alopecia effectively means understanding how styling practices shape disease. Join Oyetewa Asempa, MD, FAAD and Alexis Carrington, MD as they explore how culturally informed hair care can strengthen treatment outcomes.

0.5 CME

Evidence-Based Management of Melanocytic Neoplasms

March 23, 2026

Changing perspectives on melanocytic neoplasms are prompting reassessment of current long-standing practices. Listen as Jason Bok Lee, MD, FAAD and Hillary Johnson-Jahangir, MD, PhD, FAAD explore how risk stratification and emerging data can help refine management of pigmented lesions.

0.5 CME

Untangling the mystery of central centrifugal cicatricial alopecia: What new research insights have taught us (July JAAD)

September 1, 2025

Once believed to be derived from poor hairstyling practices, Josee Smith, MD and Crystal Aguh, MD, FAAD discuss the complex mystery of central centrifugal cicatricial alopecia, or CCCA. Learn more about new treatments and proper diagnosis to provide you patients with a better outcome from this scarring condition.

0.5 CME

High-Yield Updates on Management of Bread N' Butter Dermatologic Diseases

August 4, 2025

New treatments raise excitement in the field of dermatology, but they also lead to learning curves to optimize patient care. Listen as Erin Wei, MD, FAAD and Shawna Flanagan, MD, FAAD discusses High-Yield Updates on Management of Bread N’ Butter Dermatologic Diseases including the latest therapies and safety profiles, chemoprevention, and clinical pathology pearls.

0.5 CME